Movicol (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polymer that retains water in the intestinal lumen through osmotic activity. The added water softens the stool, expands its volume, and stimulates peristalsis, which together facilitate the passage of feces without being absorbed into the bloodstream.

The dose of Movicol is individualized by the prescribing healthcare professional based on the patient’s age, severity of constipation, and response to therapy. The prescriber determines the appropriate volume of the oral solution to be taken and the frequency of administration.

Safety data for Movicol in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing it to pregnant or breastfeeding individuals, and use it only if clearly needed.

To order Movicol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any required import documentation.

Compared with stimulant laxatives, Movicol provides a gentler, osmotic mechanism that softens stool without causing cramping. It is often preferred for long‑term management of constipation because it has a lower risk of dependence and fewer systemic side effects than some stimulant agents.

Movicol should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Movicol is taken orally as a measured dose of the clear solution. The prescribed volume is usually mixed with water or a suitable beverage, shaken gently, and consumed according to the healthcare professional’s instructions.

Serious risks include electrolyte imbalance, severe dehydration, and allergic reactions such as rash or difficulty breathing. Patients should seek immediate medical attention if they experience symptoms like rapid heartbeat, muscle weakness, severe abdominal pain, or signs of an allergic response.

Movicol should be avoided in individuals with known hypersensitivity to any of its components, in patients with intestinal obstruction or perforation, and in those with severe renal impairment where fluid balance cannot be closely monitored.